why choose us

300×250 Ad Slot

Research Article: Cardiovascular toxicity of tisagenlecleucel in children and adolescents: analysis of spontaneous reports submitted to FAERS

Date Published: 2025-01-22

Abstract:
Background: The advent of tisagenlecleucel has been a major advance in the pharmacological treatment of relapsed/refractory B-cell acute lymphoblastic leukemia in children and adolescents. However, further research is required to better define its safety profile.

Introduction:
Objectives: To determine the cardiovascular toxicity of tisagenlecleucel in children and adolescents.

Read more

300×250 Ad Slot